Papaverine ameliorates prenatal alcohol‐induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress
- 11 November 2020
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 81 (1) , 71-81
Abstract
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with complex aetiology and phenotypes. Phosphodiesterase10A (PDE10A) has been shown to provide benefits in various brain conditions. We investigated the role of papaverine, a selective PDE10A inhibitor on core phenotypes in prenatal alcohol exposure (PAE) model of ADHD. In order to identify probable mechanisms involved, the effects on several protein markers of neuronal function such as, neuronal survival‐BDNF, neuronal transcription factor‐pCREB, brain inflammation (IL‐6, IL‐10, and TNF‐α), and brain oxidative stress (TBARS and GSH) were studied in frontal cortex, cerebellum, and striatum. PAE resulting hyper‐locomotion, inattention, and anxiety were studied by the use of open‐field, y‐maze, and elevated plus maze, respectively. Administration of papaverine (15/30 mg kg−1) to PAE group of animals resulted in amelioration of hyperactivity, inattention, and anxiety. Also, papaverine resulted in significant increase of the levels in BDNF, pCREB, IL‐10, and GSH along with significant decrease of TNF‐α, IL‐6, and TBARS in different brain areas of PAE group. Papaverine, a selective PDE10A inhibitor rectified behavioural phenotypes associated with ADHD, possibly by altering the protein markers associated with neuronal survival, neuronal transcription factor, brain inflammation, and brain oxidative stress. Implicating PDE10A as a possible target for furthering our understanding of ADHD phenotypes.Keywords
This publication has 57 references indexed in Scilit:
- Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological FunctionsPhysiological Reviews, 2011
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissuesNeuropharmacology, 2010
- Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluationNuclear Medicine and Biology, 2010
- Inverse correlation of brain and blood BDNF levels in a genetic rat model of depressionInternational Journal of Neuropsychopharmacology, 2009
- Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disordersMagnetic Resonance Imaging, 2009
- Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverinePsychopharmacology, 2008
- Fetal alcohol spectrum disorder-associated depression: Evidence for reductions in the levels of brain-derived neurotrophic factor in a mouse modelPharmacology Biochemistry and Behavior, 2008
- Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosisNeuropharmacology, 2006
- PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in ratsEuropean Journal of Neuroscience, 2005
- Prenatal Alcohol Exposure Causes Attention Deficits in Male Rats.Behavioral Neuroscience, 2005